Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells

Archive ouverte

Maarifi, Ghizlane | Lagisquet, Justine | Hertel, Quentin | Bonaventure, Boris | Chamontin, Célia | Fuchs, Kyra | Moncorgé, Olivier | Tauziet, Marine | Mombled, Margaux | Papin, Laure | Molès, Jean‐pierre | Bodet, Charles | Lévèque, Nicolas | Gross, Antoine | Arhel, Nathalie, J | Nisole, Sébastien | van de Perre, Philippe | Goujon, Caroline | Blanchet, Fabien P.

Edité par CCSD ; EMBO Press -

International audience. Dendritic cells (DC) subsets, like Langerhans cells (LC), are immune cells involved in pathogen sensing. They express specific antimicrobial cellular factors that are able to restrict infection and limit further pathogen transmission. Here, we identify the alarmin S100A9 as a novel intracellular antiretroviral factor expressed in human monocyte‐derived and skin‐derived LC. The intracellular expression of S100A9 is decreased upon LC maturation and inversely correlates with enhanced susceptibility to HIV‐1 infection of LC. Furthermore, silencing of S100A9 in primary human LC relieves HIV‐1 restriction while ectopic expression of S100A9 in various cell lines promotes intrinsic resistance to both HIV‐1 and MLV infection by acting on reverse transcription. Mechanistically, the intracellular expression of S100A9 alters viral capsid uncoating and reverse transcription. S100A9 also shows potent inhibitory effect against HIV‐1 and MMLV reverse transcriptase (RTase) activity in vitro in a divalent cation‐dependent manner. Our findings uncover an unexpected intracellular function of the human alarmin S100A9 in regulating antiretroviral immunity in Langerhans cells.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion